Literature DB >> 15902767

FDA pharmacogenomics guidance sends clear message to industry.

Mark Ratner.   

Abstract

Mesh：

Year:  2005        PMID： 15902767     DOI： 10.1038/nrd1745

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer.

Authors:  So Hee Dho; Soo Yong Kim; Chaeuk Chung; Eun Ha Cho; So-Young Lee; Ji Young Kim; Lark Kyun Kim; Sung-Won Min; Jichul Lee; Sung Hee Jung; Jae Cheong Lim
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.